Sign inJoin free

Watch / China

Is now the right time to invest in Chinese equities?

22 Jan 20244:37

Is now the right time to invest in Chinese equities?

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

Key Takeaways:

  • Outlook on China's economy in light of recent GDP data

  • Pressures on the Chinese equity market and potential value

  • New energy and high-tech sectors are marked as most 'promising' in China

  • The Chinese healthcare sector set to benefit from overseas expansion

Alice Shen from VanEck discussed the pressure on China's economy, citing the main pillars as the labour market, goods market, and financial market. She says the labour market is under stress due to skill set mismatch, an issue, she says, that will likely persist until the economy transitions to high-end manufacturing and service. Turning to the goods market, Alice sees commodities and energy-related sectors as strong performers, while noting the downturn in the Chinese housing sector.

Alice then shares her views on the Chinese financial market, where she says she sees potential value despite the pressures that equities face. She points out that the valuations look 'attractive', regardless of the metrics used, and mentions how these figures trade well below the standard deviation for the past decade. Moreover, she says international markets such as Japan and India, are already 'crowded and volatile', making China a more viable option.

Looking at sectors with the most opportunity, Alice says new energy and high-tech sectors like EVs, solar, and semiconductors, have started to contribute more to China's GDP growth. Notably, government subsidies are aiding these sectors in their path to growth. Alice then says the Chinese healthcare sector is another promising area, particularly pharmaceutical and biotech companies with innovative drug pipelines poised to benefit from overseas business expansion.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy